---
category: news
title: "Medtronic Announces FDA Clearance and Results of Artificial Intelligence Algorithms for Cardiac Monitoring"
excerpt: "AI Algorithms Enhance LINQ IIâ„¢ Insertable Cardiac Monitor Diagnostic Accuracy for Improved Management of Patients. DUBLIN, July 28, 2021 /PRNewswire/ -- Medtronic plc (NYSE:MDT)"
publishedDateTime: 2021-07-28T12:00:00Z
originalUrl: "https://apnews.com/press-release/pr-newswire/technology-business-health-artificial-intelligence-b141602c5a3673193eda5ee0783cb277"
webUrl: "https://apnews.com/press-release/pr-newswire/technology-business-health-artificial-intelligence-b141602c5a3673193eda5ee0783cb277"
type: article
quality: 19
heat: -1
published: false

provider:
  name: Associated Press
  domain: apnews.com

topics:
  - AI

images:
  - url: "https://apnews.com/images/PaidContent3.png"
    width: 700
    height: 450
    isCached: true

related:
  - title: "Medtronic : FDA Approves Artificial Intelligence Algorithms For Cardiac Monitoring"
    excerpt: "U.S. Food and Drug Administration has approved two AccuRhythm AI algorithms for use with the LINQ II insertable cardiac monitor or ICM, Medtronic plc (MDT) said in a statement. AccuRhythm AI applies artificial intelligence (AI) to heart rhythm event data collected by LINQ II,"
    publishedDateTime: 2021-07-28T12:28:00Z
    webUrl: "https://www.nasdaq.com/articles/medtronic-%3A-fda-approves-artificial-intelligence-algorithms-for-cardiac-monitoring-2021-07"
    type: article
    provider:
      name: Nasdaq
      domain: nasdaq.com
    quality: 41

secured: "7GBJ4lXhFXf1u9XWpdLN0ge3e6H72VZMrNeO66oZPxHJeOOckOJK/Ly3yEWnL39Ob6cj+zp2aFdjepgMESINY8VE7hn+DOj9LCN8nU3sW/Y9vxftiHDBGyHKi0V4VRdgz4WfBQKkQ8aaLaR+N9Dk6yxoF7Y9Lw2JSHvNYvft/EloJRnN9e0W35/qd1ZmkFuX/YK+ugGWJ0kf78dgUC5SmXE5n+Aa+RkvVZ/4bv199T3MWlt2QJFbBCZPp1W7d5gRF7flIOUcerxJaTXqAFmAj11FpHSSd4e06mY9jX/ruJTZhxHVJHPfk7xFbzpwr/MKyGMRDk3r/z9gv4oyaa65bZ5SjQvQq+A0BmhFnlHkeQ0=;UQwyyC2RCkuRc+otnwM6ng=="
---

